|
WHO Model List of Essential Medicines (2021)
|
12.5.1 Anti-platelet medicines
|
No observations
|
|
Ecuador
|
Essential Medicines List - Ecuador
|
No observations
|
|
Trinidad and Tobago. Pharmaceutical Ven Listing 2019. Ministry of Health.
|
Antiplatelet Drugs
|
No observations
|
|
Costa Rica. Caja Costarricense de Seguro Social. 2019
|
11. Agentes anticoagulantes, trombolíticos y antiplaquetarios
|
Others observations:
como bisulfato. Tableta recubierta.
|
|
Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015
|
01.09 ANTI-COAGULANTAND ANTI-PLATELET DRUGS
|
No observations
|
|
Mexico. Cuadro Basico de Medicamentos - 2017
|
03. CARDIOLOGIA
|
No observations
|
|
Mexico. Cuadro Basico de Medicamentos - 2017
|
03. CARDIOLOGIA
|
No observations
|
|
Brasil. Relação Nacional de Medicamentos Essenciais. 2020
|
B. SANGUE E ÓRGÃOS HEMATOPOÉTICOS
|
No observations
|
|
Paraguay. Lista de Medicamentos Esenciales. 2009
|
01. AGENTES ANTITROMBÓTICOS
|
No observations
|
|
El Salvador - 2019
|
AGENTES ANTITROMBÓTICOS
|
No observations
|
|
WHO Model List of Essential Medicines (2021)
|
12.5.1 Anti-platelet medicines
|
No observations
|
|
Guyana. Essential Medicines List. 2020-2021
|
Reserved for specialist use
|
No observations
|
|
Guyana. Essential Medicines List. 2020-2021
|
Reserved for specialist use
|
No observations
|
|
Organisation of Eastern Caribbean States. Medical Products List. 2019-2021
|
20.12 Anticoagulants & Coagulants
|
No observations
|
|
Haiti. National List of Essential Medicines
|
12.05.01. Anti-platelet drugs
|
No observations
|
|
Barbados. Barbados National Drug Formulary (BNDF)
|
20.12.18 Platelet Aggregation Inhibitors
|
No observations
|
|
Bahamas. Drug Formulary
|
11. BLOOD PRODUCTS AND DRUGS AFFECTING THE BLOOD
|
No observations
|
|
Cayman Islands Health Services Authority Pharmacy Drug Formulary
|
02.09 Antiplatelet Drugs
|
No observations
|
